Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.84

+2.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (20353)	5/11/1998 9:35:00 AM
From: Henry Niman	Read Replies (1) of 32384

IMCL CEO was just on. He focused on monoclonals directed against growth factor receptors. He thought that combos would be used in the future. IND for their anti-angiogenesis monoclonal is slated for next year. Mentioned GNE's Herceptin (its similar to IMCL's C225 which targets HER1 - GNE's monoclonal is against HER2). IMCL traded at $14 before the open, but opened at 13 3/8 and quickly fell below $13. Jim McCamant is due on soon.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next